aTyr Pharma, Inc.ATYRNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank97
3Y CAGR+1.9%
5Y CAGR+12.6%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+1.9%/yr
vs +117.2%/yr prior
5Y CAGR
+12.6%/yr
Recent deceleration
Acceleration
-115.3pp
Decelerating
Percentile
P97
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 45.76% |
| Q3 2025 | -31.81% |
| Q2 2025 | -31.26% |
| Q1 2025 | 0.58% |
| Q4 2024 | 13.28% |
| Q3 2024 | -5.84% |
| Q2 2024 | -5.26% |
| Q1 2024 | -4.95% |
| Q4 2023 | -30.16% |
| Q3 2023 | 8.09% |
| Q2 2023 | -3.24% |
| Q1 2023 | -58.90% |
| Q4 2022 | 43.21% |
| Q3 2022 | -6.63% |
| Q2 2022 | -2.20% |
| Q1 2022 | -41.99% |
| Q4 2021 | -11.63% |
| Q3 2021 | 26.21% |
| Q2 2021 | -45.31% |
| Q1 2021 | -44.99% |
| Q4 2020 | 25.26% |
| Q3 2020 | -2.37% |
| Q2 2020 | -467.71% |
| Q1 2020 | 129.35% |
| Q4 2019 | -5.81% |
| Q3 2019 | 3.47% |
| Q2 2019 | 4.71% |
| Q1 2019 | 2.93% |
| Q4 2018 | 11.13% |
| Q3 2018 | 31.67% |
| Q2 2018 | 2.39% |
| Q1 2018 | 7.03% |
| Q4 2017 | -2.54% |
| Q3 2017 | 7.81% |
| Q2 2017 | 9.45% |
| Q1 2017 | -6.68% |
| Q4 2016 | 9.07% |
| Q3 2016 | 10.17% |
| Q2 2016 | 4.38% |
| Q1 2016 | 2.46% |